150 related articles for article (PubMed ID: 23934067)
1. Sweeping lymph node micrometastases off their feet: an engineered model to evaluate natural killer cell mediated therapeutic intervention of circulating tumor cells that disseminate to the lymph nodes.
Chandrasekaran S; McGuire MJ; King MR
Lab Chip; 2014 Jan; 14(1):118-27. PubMed ID: 23934067
[TBL] [Abstract][Full Text] [Related]
2. Super natural killer cells that target metastases in the tumor draining lymph nodes.
Chandrasekaran S; Chan MF; Li J; King MR
Biomaterials; 2016 Jan; 77():66-76. PubMed ID: 26584347
[TBL] [Abstract][Full Text] [Related]
3. Biological significance of isolated tumor cells and micrometastasis in lymph nodes evaluated using a green fluorescent protein-tagged human gastric cancer cell line.
Yokoyama H; Nakanishi H; Kodera Y; Ikehara Y; Ohashi N; Ito Y; Koike M; Fujiwara M; Tatematsu M; Nakao A
Clin Cancer Res; 2006 Jan; 12(2):361-8. PubMed ID: 16428473
[TBL] [Abstract][Full Text] [Related]
4. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
5. Micrometastatic cancer cells in lymph nodes, bone marrow, and blood: Clinical significance and biologic implications.
Leong SP; Tseng WW
CA Cancer J Clin; 2014; 64(3):195-206. PubMed ID: 24500995
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors of isolated tumor cells and micrometastases in axillary lymph nodes in breast cancer.
Madsen EV; Elias SG; van Dalen T; van Oort PM; van Gorp J; Gobardhan PD; Bongers V
Breast; 2013 Oct; 22(5):748-52. PubMed ID: 23313060
[TBL] [Abstract][Full Text] [Related]
7. Cross-validation of three predictive tools for non-sentinel node metastases in breast cancer patients with micrometastases or isolated tumor cells in the sentinel node.
Tvedskov TF; Meretoja TJ; Jensen MB; Leidenius M; Kroman N
Eur J Surg Oncol; 2014 Apr; 40(4):435-41. PubMed ID: 24534362
[TBL] [Abstract][Full Text] [Related]
8. Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.
Ouldamer L; Arbion F; Balagny A; Fourquet F; Marret H; Body G
Breast; 2013 Oct; 22(5):787-92. PubMed ID: 23473772
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of micrometastases in the lymph nodes of patients with resectable lung cancer].
Osaki T; Yasumoto K
Nihon Geka Gakkai Zasshi; 2013 Jan; 114(1):28-33. PubMed ID: 23457942
[TBL] [Abstract][Full Text] [Related]
10. [Multi-antibody combined determination of lymph node micrometastasis in patients with gastric cancer].
Wang GY; Wang SJ; Li Y; Wang LL; Wang XL; Song ZC; Fan LQ
Ai Zheng; 2004 May; 23(5):559-63. PubMed ID: 15142454
[TBL] [Abstract][Full Text] [Related]
11. Is lymph-node micrometastasis in gallbladder cancer a significant prognostic factor?
Tanabe M; Endo I; Masunari H; Sugita M; Morioka D; Ishikawa T; Ichikawa Y; Shimada H
Hepatogastroenterology; 2012; 59(113):31-5. PubMed ID: 22251520
[TBL] [Abstract][Full Text] [Related]
12. [Detection of micrometastasis in patients with colorectal cancer].
Shimada Y; Ajioka Y; Wakai T
Nihon Rinsho; 2014 Jan; 72(1):89-94. PubMed ID: 24597354
[TBL] [Abstract][Full Text] [Related]
13. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
[TBL] [Abstract][Full Text] [Related]
14. The impact of method of biopsy on the incidence of breast cancer sentinel lymph node metastases.
Meattini I; Giannotti E; Abdulcadir D; Saieva C; Guerrieri AM; Vanzi E; Scartoni D; Cecchini S; Sanchez LJ; Orzalesi L; Casella D; Bianchi S; Livi L; Nori J
Eur J Surg Oncol; 2014 Mar; 40(3):277-81. PubMed ID: 24388742
[TBL] [Abstract][Full Text] [Related]
15. NK cells-directed therapies target circulating tumor cells and metastasis.
Dianat-Moghadam H; Mahari A; Heidarifard M; Parnianfard N; Pourmousavi-Kh L; Rahbarghazi R; Amoozgar Z
Cancer Lett; 2021 Jan; 497():41-53. PubMed ID: 32987138
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer.
Morton BA; Ramey WG; Paderon H; Miller RE
Cancer Res; 1986 Apr; 46(4 Pt 2):2121-6. PubMed ID: 3081262
[TBL] [Abstract][Full Text] [Related]
17. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow.
Weitz J; Kienle P; Magener A; Koch M; Schrödel A; Willeke F; Autschbach F; Lacroix J; Lehnert T; Herfarth C; von Knebel Doeberitz M
Clin Cancer Res; 1999 Jul; 5(7):1830-6. PubMed ID: 10430088
[TBL] [Abstract][Full Text] [Related]
18. Identification of micrometastases in histologically negative lymph nodes of early-stage cervical cancer patients.
Lentz SE; Muderspach LI; Felix JC; Ye W; Groshen S; Amezcua CA
Obstet Gynecol; 2004 Jun; 103(6):1204-10. PubMed ID: 15172853
[TBL] [Abstract][Full Text] [Related]
19. Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years.
Gebauer G; Fehm T; Merkle E; Jaeger W; Mitze M
Anticancer Res; 2003; 23(5b):4319-24. PubMed ID: 14666645
[TBL] [Abstract][Full Text] [Related]
20. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
